Hungarian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

glaucoma/epilepsziás roham

A hivatkozás a vágólapra kerül
Oldal 1 tól től 26 eredmények

Cyclohexylamine derivatives as subtype selective N-Methyl-D-Aspartate antagonists

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
FIELD OF THE INVENTION The invention provides cyclohexylamine derivatives as N-Methyl-D-Aspartate (NMDA) antagonists, pharmacological compositions comprising the derivatives, and methods of treating diseases and disorders responsive to antagonism of NMDA receptors using the derivatives. BACKGROUND

Substituted 2,3-benzodiazepin-4-ones and the use thereof

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
This application claims benefit of U.S. provisional application Ser. No. 60/013,813 filed Mar. 21, 1996. BACKGROUND OF THE INVENTION 1. Field of the Invention This invention is in the field of medicinal chemistry. In particular, the invention relates to novel substituted 2,3-benzodiazepin-4-ones.

4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention is related to 4-substituted piperidine analogs, including hydroxypiperidine and tetrahydropyridine analogs, as well as novel intermediates of the 4-substituted analogs. The analogs are selectively active as antagonists of

4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention is related to 4-substituted piperidine analogs, including hydroxypiperidine and tetrahydropyridine analogs, as well as novel intermediates of the 4-substituted analogs. The analogs are selectively active as antagonists of

2-substituted piperidine analogs and their use as subtype-selective NMDA receptor antagonists

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention is related to 2-substituted piperidine analogs. The analogs are selectively active as antagonists of N-methyl-D-aspartate (NMDA) receptor subtypes. The invention is also directed to the use of 2-substituted piperidine analogs as

2-substituted piperidine analogs and their use as subtype-selective NMDA receptor antagonists

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention is related to 2-substituted piperidine analogs. The analogs are selectively active as antagonists of N-methyl-D-aspartate (NMDA) receptor subtypes. The invention is also directed to the use of 2-substituted piperidine analogs as

4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention is related to 4-substituted piperidine analogs, including hydroxypiperidine and tetrahydropyridine analogs. The analogs are selectively active as antagonists of N-methyl-D-aspartate (NMDA) receptor subtypes. The invention is also

Piperidine derivatives as subtype selective N-Methyl-D-Aspartate antagonists

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
FIELD OF INVENTION The invention relates to piperidine derivatives as N-Methyl-D-Aspartate (NMDA) antagonists useful in the treatment of diseases and disorders responsive to antagonism of NMDA receptors. BACKGROUND OF THE INVENTION Many of the physiological and pathophysiological effects of the

Compositions and methods for the suppression of carbonic anhydrase activity

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
PRIORITY This application is a national phase filing of the Patent Cooperation Treaty (PCT) application # PCT/IB2013/050899 titled "COMPOSITIONS AND METHODS FOR THE SUPPRESSION OF CARBONIC ANHYDRASE ACTIVITY" filed on Feb. 3, 2013 Published with WIPO Publication # WO/2013/167994, which further

Method and composition for treatment of ischemic neuronal reperfusion injury

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
FIELD OF THE INVENTION This invention relates to the treatment of neuropathy resulting from ischemic reperfusion injury in a mammal. Such neuropathies include, but are not limited to, optic ischemic neuropathy, stroke, reperfusion injury after TPA treatment or other lytic treatments/carotid

Imidazoline compounds

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
TECHNICAL FIELD The present invention is useful in medical fields. In more detail, novel imidazoline compounds of this invention are useful as neuropeptide Y receptor antagonists and as agents for the treatment of various kinds of cardiovascular disorders, central nervous system disorders, metabolic

Imidazonline compounds

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
This application is a 371 of PCT/JP01/01312 filed Feb. 22, 2001. TECHNICAL FIELD The present invention is useful in medical fields. In more detail, novel imidazoline compounds of this invention are useful as neuropeptide Y receptor antagonists and as agents for the treatment of various kinds of

Compositions and methods for the treatment of moderate to severe pain

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
PRIORITY The present application claims the benefit of Indian Provisional Patent Application No. 1840/CHE/2012 filed on 10 May 2012 and the International Application No. PCT/IB2013/050924 filed on 4 Feb. 2013, the entire disclosure of which is relied on for all purposes and is incorporated into this

Adenosine receptor agonists, partial agonists, and antagonists

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
BACKGROUND OF THE INVENTION There are four subtypes of receptors for adenosine, designated A.sub.1, A.sub.2A, A.sub.2B, and A.sub.3. The A.sub.3 adenosine receptor is found primarily in the central nervous system, brain, testes, and the immune system, where it appears to be involved in the

Substituted [1,2,4]triazolo[4,3-a]pyrazines as P2X7 modulators

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
CROSS REFERENCE TO RELATED APPLICATIONS This application is a national phase of International Application No. PCT/US2014/027450 filed on Mar. 14, 2014, which claims the benefit of U.S. Provisional Application No. 61/785,478 filed on Mar. 14, 2013, each of which are incorporated herein by reference
Csatlakozzon
facebook oldalunkhoz

A legteljesebb gyógynövény-adatbázis, amelyet a tudomány támogat

  • Működik 55 nyelven
  • A tudomány által támogatott gyógynövényes kúrák
  • Gyógynövények felismerése kép alapján
  • Interaktív GPS térkép - jelölje meg a gyógynövényeket a helyszínen (hamarosan)
  • Olvassa el a keresésével kapcsolatos tudományos publikációkat
  • Keresse meg a gyógynövényeket hatásuk szerint
  • Szervezze meg érdeklődését, és naprakész legyen a hírkutatással, a klinikai vizsgálatokkal és a szabadalmakkal

Írjon be egy tünetet vagy betegséget, és olvassa el azokat a gyógynövényeket, amelyek segíthetnek, beírhat egy gyógynövényt, és megtekintheti azokat a betegségeket és tüneteket, amelyek ellen használják.
* Minden információ publikált tudományos kutatáson alapul

Google Play badgeApp Store badge